Oxford Nanopore Technologies
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Oxford, Oxfordshire, United Kingdom, Europe
Region: Oxfordshire
Country: GB
Continent: Europe
About
Oxford Nanopore Technologies develops nanopore sequencing devices and accompanying analysis tools for real-time, long-read genomic sequencing. The company offers portable and high-throughput sequencing solutions aimed at research and clinical applications, spanning human, microbial, plant, environmental, and cancer genomics. Headquartered in the UK, it operates globally with devices like MinION, GridION, and PromethION, and provides resources, training, and support for researchers across multiple disciplines.
Oxford Nanopore Technologies develops nanopore sequencing devices and analysis tools for real-time, long-read genomic sequencing. The company provides portable and high-throughput solutions for research and clinical applications in human, microbial, and environmental genomics. Its product lineup includes the MinION, GridION, and PromethION sequencers.
Oxford Nanopore Technologies Ltd
2005
for_profit
active
Industries
Primary Industry: Manufacturing
Categories
Funding & Financials
Public Company
1200000000
200m-1b
ipo
LSE:ONT.L
lse
Investors
Founders
Gordon Sanghera
Hagan Bayley
Spike Willcocks
Leadership
Clive G. Brown — Directorships
John Milton — Chief Scientific Officer
Richard Compton — Senior Vice President of Commercial Operations
Alan Aubrey — Non Executive Director
Adam Goldfarb — Associate Director, Legal Counsel
Sara Agee Le — VP of Technical Marketing
Helen Bowyer — HR Manager UK & Europe
Technology Stack
Products
MinION: A portable, palm-sized DNA/RNA sequencer designed for real-time, on-site genomic analysis.
PromethION 2: A high-output nanopore sequencing device designed for flexible, large-scale genomic projects.
GridION: A benchtop sequencing device capable of running multiple MinION flow cells for medium-scale genomic sequencing.
Flongle: A small, on-demand flow cell adapter for rapid, low-throughput nanopore sequencing tests or experiments.
Nanopore Flow Cells and Library Preparation Kits: Consumables including flow cells and kits for preparing DNA/RNA samples for nanopore sequencing.
EPI2ME: A cloud-based data analysis platform for processing and interpreting nanopore sequencing data.
Funding rounds
Post Ipo Equity · $63.64M · (2024-08-01) · Lead: Novo Holdings
Post Ipo Equity · $84.95M · (2023-10-19) · Lead: bioMerieux
IPO · (2021-09-30)
